Mexico Pet Care Products Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MEXICO PET CARE PRODUCTS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET APPLICATION COVERAGE GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER FIVE FORCES

4.2 PESTLE ANALYSIS

4.2.1 POLITICAL FACTORS

4.2.2 ECONOMIC FACTORS

4.2.3 SOCIAL FACTORS

4.2.4 TECHNOLOGICAL FACTORS

4.2.5 ENVIRONMENTAL FACTORS

4.2.6 LEGAL FACTORS

4.3 PIPELINE ANALYSIS

4.3.1 CLINICAL DEVELOPMENT AND PHASE ANALYSIS

4.3.2 PRODUCT PIPELINE FOR ANIMAL PARASITICIDES

4.3.3 TARGET ANIMAL SAFETY STUDIES (TASS)

4.3.4 TARGET ANIMAL EFFECTIVENESS STUDIES (TAES)

4.4 PATENT ANALYSIS

4.4.1 PATENT NUMBER AND EXPIRY

4.4.2 COUNTRY-LEVEL APPROVAL

4.4.3 LIST OF PRODUCTS REACHING EXPIRY IN NEXT 3 YEARS

4.4.4 PRODUCTS PATENTED IN SPECIFIC COUNTRIES

4.4.5 CONCLUSION

4.5 INDUSTRY INSIGHTS

4.5.1 MICRO AND MACRO ECONOMIC FACTORS

4.5.1.1 RISING PET OWNERSHIP AND HOUSEHOLD PET PENETRATION SUPPORTING MARKET EXPANSION

4.5.1.2 URBANIZATION AND EXPANSION OF VETERINARY HEALTHCARE INFRASTRUCTURE

4.5.1.3 INFLATION AND EXCHANGE RATE VOLATILITY INFLUENCING VETERINARY PRODUCT PRICING

4.5.1.4 GROWTH OF DIGITAL COMMERCE EXPANDING ACCESS TO PET HEALTHCARE PRODUCTS

4.5.1.5 INCREASING HOUSEHOLD EXPENDITURE ON COMPANION ANIMAL CARE

4.5.1.6 DEPENDENCE ON IMPORTED VETERINARY PRODUCTS AND PHARMACEUTICAL INPUTS

4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING

4.5.2.1 RISING PENETRATION OF PREVENTIVE VETERINARY HEALTHCARE AMONG COMPANION ANIMALS

4.5.3 KEY PRICING STRATEGIES

4.5.3.1 VALUE-BASED PRICING FOR PREMIUM VETERINARY THERAPEUTICS

4.5.3.2 COMPETITIVE PRICING ACROSS PRESCRIPTION AND OVER-THE-COUNTER PRODUCT PORTFOLIOS

4.5.3.3 CHANNEL-BASED PRICING TO OPTIMIZE MARKET COVERAGE

4.5.3.4 PORTFOLIO DIVERSIFICATION AND PACK-SIZE PRICING STRATEGIES

4.5.4 ANALYSIS AND RECOMMENDATION

4.5.4.1 STRENGTHEN PREVENTIVE HEALTHCARE PRODUCT PORTFOLIOS

4.5.4.2 EXPAND PRESENCE IN UNDERSERVED AND RURAL MARKETS

4.5.4.3 INVEST IN LOCAL MANUFACTURING AND SUPPLY CHAIN RESILIENCE

4.5.4.4 ACCELERATE DIGITAL TRANSFORMATION AND OMNICHANNEL DISTRIBUTION

4.5.5 SUPPLY CHAIN RESILIENCE

4.5.5.1 DIVERSIFICATION OF PET CARE RAW MATERIAL AND MANUFACTURING SUPPLIERS

4.5.5.2 ESTABLISHMENT OF LOCAL PRODUCTION AND FILL-FINISH HUBS

4.5.5.3 STRATEGIC STOCKPILING OF CORE PET CARE PRODUCTS

4.5.5.4 DEVELOPMENT OF ALTERNATIVE LOGISTICS AND DISTRIBUTION ROUTES

4.5.5.5 STRATEGIC PARTNERSHIPS WITH CONTRACT MANUFACTURERS (CDMOS)

4.5.5.6 EXPANSION OF PET PRODUCT MANUFACTURING AND PACKAGING CAPABILITIES

4.5.6 ENERGY & MANUFACTURING OPERATIONAL COST RISK

4.5.6.1 RISING ENERGY COSTS AFFECTING PRODUCTION FACILITIES

4.5.6.2 INCREASED COSTS FOR RAW MATERIALS AND INGREDIENTS

4.5.6.3 LONG-TERM ENERGY PROCUREMENT STRATEGIES

4.5.6.4 ADOPTION OF ENERGY-EFFICIENT TECHNOLOGIES

4.5.6.5 ADVANCED AUTOMATION AND CONTINUOUS MANUFACTURING

4.5.6.6 INTEGRATION OF RENEWABLE ENERGY SOURCES

4.5.7 GEOGRAPHIC FOOTPRINT REASSESSMENT

4.5.7.1 EXPANSION OF MANUFACTURING IN STABLE REGIONS

4.5.7.2 DIVERSIFICATION OF SUPPLY BASE

4.5.7.3 RELOCATION OF MANUFACTURING FACILITIES

4.5.7.4 EXPANSION IN EMERGING MARKETS WITHIN MEXICO

4.5.7.5 REGIONAL DISTRIBUTION AND COLD CHAIN HUBS

4.5.8 SCENARIO PLANNING & RISK MANAGEMENT

4.5.8.1 DEVELOPMENT OF SUPPLY CHAIN CONTINGENCY PLANS

4.5.8.2 MULTI-SOURCE PROCUREMENT STRATEGIES

4.5.8.3 GOVERNMENT AND PUBLIC HEALTH AUTHORITY COLLABORATIONS

4.5.8.4 CRISIS-RESPONSE SUPPLY NETWORKS

4.5.8.5 DEPLOYMENT OF PREDICTIVE SUPPLY CHAIN ANALYTICS

4.5.9 NEW BUSINESS, EMERGING REVENUE OPPORTUNITIES & FUTURE OUTLOOK

4.5.9.1 EXPANSION OF PREVENTIVE HEALTHCARE AND SUBSCRIPTION-BASED WELLNESS PROGRAMS

4.5.9.2 GROWTH OPPORTUNITIES IN DIGITAL VETERINARY SERVICES AND E-COMMERCE

4.5.9.3 INCREASING INVESTMENT IN PREMIUM AND INNOVATIVE VETERINARY THERAPEUTICS

4.5.9.4 EXPANSION OF VETERINARY HEALTHCARE INFRASTRUCTURE IN UNDERSERVED REGIONS

4.5.9.5 POSITIVE LONG-TERM MARKET OUTLOOK SUPPORTED BY PET HUMANIZATION AND HEALTHCARE AWARENESS

4.6 EPIDEMIOLOGY

4.6.1 PET OWNERSHIP LEVELS BY TYPE

4.6.2 PET HEALTHCARE ACCESS RATES

4.6.3 PET LIFESPAN AND MORTALITY TRENDS

4.6.4 PRODUCT USAGE ADHERENCE AND SWITCH MODEL

4.6.4.1 PREVENTIVE PRODUCT USAGE ADHERENCE

4.6.4.2 FACTORS AFFECTING PRODUCT ADHERENCE

4.6.4.3 PRODUCT SWITCHING MODEL

4.6.5 BRAND LOYALTY AND RETENTION TRENDS

4.6.6 SUCCESS RATES FOR PET TREATMENTS

4.6.6.1 ANTIPARASITIC TREATMENT SUCCESS RATES

4.6.6.2 ANTIMICROBIAL TREATMENT SUCCESS RATES

4.6.6.3 SURGICAL AND ANESTHESIA TREATMENT OUTCOMES

4.6.6.4 CHRONIC DISEASE MANAGEMENT OUTCOMES

4.7 MARKETED PRODUCT ANALYSIS

4.7.1 INTRODUCTION

4.7.2 PRODUCT

4.7.2.1 BRAND NAME

4.7.2.2 GENERIC NAME

4.7.3 INDICATION

4.7.4 PHARMACOLOGICAL CLASSIFICATION

4.7.5 PRIMARY INDICATION

4.7.6 MARKET STATUS

4.7.7 PRODUCT TYPE

4.7.8 PRODUCT DOSAGE FORM

4.7.9 DOSAGE AVAILABILITY

4.7.10 PACKAGING TYPE

4.7.11 ROUTE OF ADMINISTRATION

4.7.12 DOSING FREQUENCY

4.7.13 PRODUCT INSIGHT

4.8 MARKET ACCESS

4.8.1 TEN-YEAR MARKET FORECAST

4.8.2 CLINICAL TRIAL / NEW PRODUCT UPDATES

4.8.3 ANNUAL NEW PRODUCT LAUNCHES & REGISTRATIONS

4.8.4 MANUFACTURERS AND PARTNERSHIP DEALS

4.8.5 MAJOR PRODUCT ADOPTION AND UPTAKE

4.8.6 CURRENT PET CARE PRACTICES

4.9 IMPACT OF UPCOMING PRODUCTS AND INNOVATIONS

4.9.1 CONCLUSION

4.1 R&D ANALYSIS

4.10.1 COMPARATIVE ANALYSIS

4.10.1.1 COMPANION ANIMAL THERAPEUTICS RECEIVE GREATER R&D FOCUS THAN LIVESTOCK-ORIENTED PRODUCTS

4.10.1.2 PREVENTIVE HEALTHCARE PRODUCTS DEMONSTRATE HIGHER DEVELOPMENT ACTIVITY THAN THERAPEUTIC MEDICINES

4.10.1.3 ADVANCED FORMULATIONS ARE REPLACING CONVENTIONAL DOSAGE FORMS

4.10.1.4 INCREASING INVESTMENT IN VETERINARY RESEARCH STRENGTHENS PRODUCT INNOVATION

4.10.2 DEVELOPMENTAL LANDSCAPE

4.10.2.1 GROWING DEVELOPMENT OF PREVENTIVE AND LONG-ACTING COMPANION ANIMAL THERAPIES

4.10.2.2 EXPANSION OF VETERINARY BIOLOGICALS AND IMMUNOLOGICAL PRODUCTS

4.10.2.3 INCREASING DIGITALIZATION OF VETERINARY PHARMACOVIGILANCE AND PRODUCT MONITORING

4.10.2.4 STRENGTHENING RESEARCH THROUGH GOVERNMENT–ACADEMIC COLLABORATION

4.10.3 IN-DEPTH INSIGHTS ON REGULATORY MILESTONES

4.10.3.1 IMPLEMENTATION OF MEXICO'S VETERINARY PHARMACOVIGILANCE SYSTEM STRENGTHENED POST-MARKET SURVEILLANCE

4.10.3.2 NOM-012-SAG/ZOO-2020 MODERNIZED THE REGULATORY FRAMEWORK FOR VETERINARY PRODUCTS

4.10.3.3 EXPANSION OF VETERINARY PRODUCT REGISTRATION SUPPORTING MARKET INNOVATION

4.10.3.4 STRENGTHENED CONTROLS AGAINST COUNTERFEIT VETERINARY MEDICINES

4.10.3.5 ALIGNMENT WITH INTERNATIONAL ANIMAL HEALTH STANDARDS

5 HEALTHCARE TARIFFS IMPACT ANALYSIS

5.1 OVERVIEW

5.2 TARIFF STRUCTURES

5.2.1 MEXICO VS. REGIONAL TARIFF STRUCTURES

5.2.2 MEXICO: PUBLIC HEALTH INSURANCE & REGULATORY PRICING

5.2.3 TRADE AGREEMENTS IMPACTING IMPORTED PRODUCTS

5.2.4 GOVERNMENT TARIFFS ON IMPORTED PET PRODUCTS

5.2.5 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION

5.2.6 TRADE BARRIERS AND IMPORT DUTIES

5.2.7 IMPORT DUTIES ON VETERINARY DRUGS VS. GENERICS

5.2.8 IMPACT ON PRODUCT AFFORDABILITY

5.2.9 TRADE AGREEMENTS IMPACTING PET SECTOR

5.3 IMPACT OF HEALTHCARE TARIFFS ON END USERS

5.3.1 COST BURDEN ON RETAILERS, VETS, PET OWNERS

5.3.2 EFFECT ON PET OWNER AFFORDABILITY AND INSURANCE COVERAGE

5.3.3 TARIFFS & MEDICAL TOURISM FOR SPECIALIST PET CARE

5.4 TRADE AGREEMENTS AND TARIFFS

5.4.1 WTO REGULATIONS ON HEALTHCARE TARIFFS

5.4.2 IMPACT OF TRADE WARS ON SUPPLY CHAIN

5.4.3 ROLE OF FTAS IN REDUCING TARIFFS

5.5 IMPACT ON COSTS AND ACCESSIBILITY

5.6 IMPORTANCE OF TARIFFS IN THE SECTOR

6 REGULATORY FRAMEWORK

6.1 INTRODUCTION

6.2 REGULATORY APPROVAL PROCESS FOR PET CARE PRODUCTS

6.3 EASE OF REGULATORY APPROVAL IN MEXICO

6.4 APPROVAL PATHWAYS FOR IMPORTED/LOCAL PRODUCTS

6.5 LICENSING AND REGISTRATION

6.6 POST-MARKETING SURVEILLANCE

6.7 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES

6.8 CONCLUSION

7 MARKET OVERVIEW

7.1 DRIVER

7.1.1 RISING PET OWNERSHIP IN MEXICO

7.1.2 GROWING AWARENESS OF COMPANION ANIMAL HEALTH AND RESPONSIBLE VETERINARY CARE

7.1.3 HIGH BURDEN OF PARASITIC AND VECTOR-BORNE DISEASES

7.1.4 EXPANSION OF VETERINARY CLINICS AND SPECIALIZED ANIMAL HEALTHCARE SERVICES ACROSS MEXICO

7.2 RESTRAINTS

7.2.1 AVAILABILITY OF COUNTERFEIT AND ILLEGAL VETERINARY MEDICINES

7.2.2 REGULATORY BURDEN AND COMPLIANCE COSTS

7.3 OPPORTUNITY

7.3.1 LOWER COST OF PET CARE COMPARED WITH THE UNITED STATES AND CANADA

7.3.2 EXPANSION OF MOBILE VETERINARY CARE FOR REMOTE AND UNDERSERVED AREAS

7.3.3 RISING APPLICATIONS OF UV FILTERS IN INDUSTRIAL COATINGS

7.4 CHALLENGES

7.4.1 INCREASING PARASITE RESISTANCE TO EXISTING ANTIPARASITIC PRODUCTS

7.4.2 MAINTAINING COLD CHAIN AND PRODUCT QUALITY

8 MEXICO PET CARE PRODUCTS MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 MEXICO PET CARE PRODUCTS MARKET, BY PRODUCT CATEGORY, 2018-2033 (USD THOUSAND)

8.2.1 ANTIPARASITICS

8.2.2 ANTIMICROBIALS

8.2.3 ANESTHETICS

8.3 MEXICO ANTIPARASITICS IN PET CARE PRODUCTS MARKET, BY PARASITE TYPE, 2018-2033 (USD THOUSAND)

8.3.1 ECTOPARASITICIDES

8.3.2 ENDOPARASITICIDES

8.3.3 ENDECTOCIDES

8.4 MEXICO ECTOPARASITICIDES IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.4.1 FLEA CONTROL

8.4.2 TICK CONTROL

8.4.3 MITE CONTROL

8.4.4 LICE CONTROL

8.5 MEXICO ENDOPARASITICIDES IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.5.1 NEMATODES

8.5.2 CESTODES

8.5.3 TREMATODES

8.6 MEXICO ANTIPARASITICS IN PET CARE PRODUCTS MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)

8.6.1 ISOXAZOLINES

8.6.2 MACROCYCLIC LACTONES

8.6.3 COMBINATION PRODUCTS

8.6.4 BENZIMIDAZOLES

8.6.5 IMIDACLOPRID-BASED PRODUCTS

8.6.6 PYRETHROIDS

8.6.7 ORGANOPHOSPHATES

8.6.8 OTHERS

8.7 MEXICO ANTIPARASITICS IN PET CARE PRODUCTS MARKET, BY FORM, 2018-2033 (USD THOUSAND)

8.7.1 TOPICAL PRODUCTS

8.7.2 ORAL PRODUCTS

8.7.3 WEARABLE PRODUCTS

8.7.4 INJECTABLE PRODUCTS

8.8 MEXICO TOPICAL PRODUCTS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.8.1 SPOT-ON SOLUTIONS

8.8.2 SHAMPOOS

8.8.3 SPRAYS

8.8.4 POWDERS

8.8.5 OTHERS

8.9 MEXICO ORAL PRODUCTS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.9.1 CHEWABLE TABLETS

8.9.2 TABLETS/DEWORMERS

8.9.3 LIQUIDS

8.1 MEXICO ANTIPARASITICS IN PET CARE PRODUCTS MARKET, BY PREVENTION TYPE, 2018-2033 (USD THOUSAND)

8.10.1 MONTHLY PREVENTION

8.10.2 QUARTERLY PREVENTION

8.10.3 ANNUAL PREVENTION

8.11 MEXICO ANTIMICROBIALS IN PET CARE PRODUCTS MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)

8.11.1 PENICILLINS

8.11.2 CEPHALOSPORINS

8.11.3 FLUOROQUINOLONES

8.11.4 MACROLIDES

8.11.5 TETRACYCLINES

8.11.6 AMINOGLYCOSIDES

8.11.7 SULFONAMIDES

8.11.8 LINCOSAMIDES

8.11.9 CARBAPENEMS

8.11.10 OTHERS

8.12 MEXICO ANTIMICROBIALS IN PET CARE PRODUCTS MARKET, BY INDICATION, 2018-2033 (USD THOUSAND)

8.12.1 SKIN & SOFT TISSUE INFECTIONS

8.12.2 RESPIRATORY INFECTIONS

8.12.3 URINARY TRACT INFECTIONS

8.12.4 GASTROINTESTINAL INFECTIONS

8.12.5 DENTAL INFECTIONS

8.12.6 OTITIS & EAR INFECTIONS

8.12.7 POST-SURGICAL INFECTIONS

8.12.8 OPHTHALMIC INFECTIONS

8.12.9 OTHERS

8.13 MEXICO ANTIMICROBIALS IN PET CARE PRODUCTS MARKET, BY FORM, 2018-2033 (USD THOUSAND)

8.13.1 ORAL PRODUCTS

8.13.2 INJECTABLE PRODUCTS

8.13.3 TOPICAL & DERMATOLOGY PRODUCTS

8.13.4 EYE & EAR PREPARATIONS

8.14 MEXICO ORAL PRODUCTS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.14.1 TABLETS

8.14.2 CHEWABLE TABLETS

8.14.3 ORAL SUSPENSIONS/SYRUPS

8.14.4 CAPSULES

8.14.5 OTHERS

8.15 MEXICO INJECTABLE PRODUCTS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.15.1 INTRAMUSCULAR

8.15.2 SUBCUTANEOUS

8.15.3 INTRAVENOUS

8.16 MEXICO TOPICAL & DERMATOLOGY PRODUCTS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.16.1 MEDICATED SHAMPOOS

8.16.2 SPRAYS

8.16.3 MEDICATED CREAMS

8.16.4 OINTMENTS

8.16.5 GELS

8.16.6 OTHERS

8.17 MEXICO EYE & EAR PREPARATIONS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.17.1 OTIC SOLUTIONS

8.17.2 OPHTHALMIC DROPS

8.17.3 OTHERS

8.18 MEXICO ANESTHETICS IN PET CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

8.18.1 GENERAL ANESTHETICS

8.18.2 LOCAL ANESTHETICS

8.18.3 SEDATIVES

8.18.4 ANALGESICS WITH ANESTHESIA

8.19 MEXICO ANESTHETICS IN PET CARE PRODUCTS MARKET, BY ADMINISTRATION ROUTE, 2018-2033 (USD THOUSAND)

8.19.1 INJECTABLE

8.19.2 INHALATION

8.19.3 TOPICAL

8.2 MEXICO ANESTHETICS IN PET CARE PRODUCTS MARKET, BY PROCEDURE TYPE, 2018-2033 (USD THOUSAND)

8.20.1 SURGICAL PROCEDURES

8.20.2 DENTAL PROCEDURES

8.20.3 DIAGNOSTIC PROCEDURES

8.20.4 ORTHOPEDIC PROCEDURES

8.20.5 EMERGENCY PROCEDURES

8.20.6 OTHERS

8.21 MEXICO ANESTHETICS IN PET CARE PRODUCTS MARKET, BY DURATION TYPE, 2018-2033 (USD THOUSAND)

8.21.1 SHORT-ACTING

8.21.2 INTERMEDIATE-ACTING

8.21.3 LONG-ACTING

9 MEXICO PET CARE PRODUCTS MARKET, BY PET TYPE

9.1 OVERVIEW

9.2 MEXICO PET CARE PRODUCTS MARKET, BY PET TYPE, 2018-2033 (USD THOUSAND)

9.2.1 DOGS

9.2.2 CATS

9.2.3 BIRDS

9.2.4 SMALL MAMMALS

9.2.5 EXOTIC PETS

9.3 MEXICO DOGS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.3.1 ADULT DOGS

9.3.2 PUPPIES

9.3.3 SENIOR DOGS

9.4 MEXICO CATS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.4.1 ADULT CATS

9.4.2 KITTENS

9.4.3 SENIOR CATS

9.5 MEXICO SMALL MAMMALS IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.5.1 RABBITS

9.5.2 HAMSTERS

9.5.3 GUINEA PIGS

9.5.4 FERRETS

10 MEXICO PET CARE PRODUCTS MARKET, BY ROUTE OF ADMINISTRATION

10.1 OVERVIEW

10.2 MEXICO PET CARE PRODUCTS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)

10.2.1 ORAL

10.2.2 TOPICAL

10.2.3 PARENTERAL

10.2.4 OTIC

10.2.5 OPHTHALMIC

10.2.6 INHALATION

10.2.7 OTHERS

10.3 MEXICO ORAL IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.3.1 TABLETS

10.3.2 CHEWABLES

10.3.3 LIQUIDS

10.3.4 CAPSULES

10.4 MEXICO TOPICAL IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.4.1 SPOT-ON

10.4.2 SHAMPOOS

10.4.3 SPRAYS

10.4.4 CREAMS

10.4.5 OTHERS

10.5 MEXICO PARENTERAL IN PET CARE PRODUCTS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.5.1 SUBCUTANEOUS

10.5.2 INTRAMUSCULAR

10.5.3 INTRAVENOUS

11 MEXICO PET CARE PRODUCTS MARKET, BY PRESCRIPTION TYPE

11.1 OVERVIEW

11.2 MEXICO PET CARE PRODUCTS MARKET, BY PRESCRIPTION TYPE, 2018-2033 (USD THOUSAND)

11.2.1 OVER-THE-COUNTER (OTC) PRODUCTS

11.2.2 PRESCRIPTION PRODUCTS

12 MEXICO PET CARE PRODUCTS MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 MEXICO PET CARE PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

12.2.1 VETERINARY CLINICS & HOSPITALS

12.2.2 PET SPECIALTY STORES

12.2.3 E-COMMERCE PLATFORMS

12.2.4 BRAND-OWNED WEBSITES

12.2.5 AGROVET STORES

12.2.6 PHARMACIES & DRUG STORES

12.2.7 SUBSCRIPTION-BASED PLATFORMS

12.2.8 SUPERMARKETS & HYPERMARKETS

12.2.9 CONVENIENCE STORES

12.2.10 OTHERS

13 MEXICO PET CARE PRODUCTS MARKET, BY FORM

13.1 OVERVIEW

13.2 MEXICO PET CARE PRODUCTS MARKET, BY FORM, 2018-2033 (USD THOUSAND)

13.2.1 DRY

13.2.2 WET

13.2.3 TABLET & CHEWABLE

13.2.4 LIQUID

13.2.5 TOPICAL

13.2.6 POWDER

13.2.7 INJECTABLE

13.2.8 SPRAY

13.2.9 OTHERS

14 MEXICO PET CARE PRODUCTS MARKET, BY PACKAGING TYPE

14.1 OVERVIEW

14.2 MEXICO PET CARE PRODUCTS MARKET, BY PACKAGING TYPE, 2018-2033 (USD THOUSAND)

14.2.1 BOTTLES

14.2.2 BOXES & CARTONS

14.2.3 BLISTER PACKS

14.2.4 TUBES & SACHETS

14.2.5 VIALS & AMPOULES

14.2.6 BULK PACKAGING

14.2.7 OTHERS

15 MEXICO PET CARE PRODUCTS MARKET, BY END USER

15.1 OVERVIEW

15.2 MEXICO PET CARE PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)

15.2.1 HOUSEHOLD PET OWNERS

15.2.2 VETERINARY INSTITUTIONS

15.2.3 PET GROOMING CENTERS

15.2.4 PROFESSIONAL BREEDERS

15.2.5 ANIMAL SHELTERS & RESCUE CENTERS

15.2.6 OTHERS

16 MEXICO PET CARE PRODUCTS MARKET

16.1 COMPANY SHARE ANALYSIS: MEXICO

17 SWOT ANALYSIS

18 COMPANY PROFILES - GLOBAL COMPANIES

18.1 ZOETIS SERVICES LLC

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 PRODUCT PORTFOLIO

18.1.4 RECENT DEVELOPMENT

18.2 MERCK & CO., INC

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENT

18.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

18.3.1 COMPANY SNAPSHOT

18.3.2 PRODUCT PORTFOLIO

18.3.3 RECENT DEVELOPMENT

18.4 ELANCO

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 PRODUCT PORTFOLIO

18.4.4 RECENT DEVELOPMENT

18.5 CEVA

18.5.1 COMPANY SNAPSHOT

18.5.2 PRODUCT PORTFOLIO

18.5.3 RECENT DEVELOPMENT

18.6 BIMEDA CORPORATE

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT/NEWS

18.7 PHIBRO

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENT/NEWS

18.8 VETNIL

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENT/NEWS

18.9 VETOQUINOL

18.9.1 COMPANY SNAPSHOT

18.9.2 REVENUE ANALYSIS

18.9.3 PRODUCT PORTFOLIO

18.9.4 RECENT DEVELOPMENT

18.1 VIRBAC

18.10.1 COMPANY SNAPSHOT

18.10.2 REVENUE ANALYSIS

18.10.3 PRODUCT PORTFOLIO

18.10.4 RECENT DEVELOPMENT

19 COMPANY PROFILES- DOMESTIC COMPANIES

19.1 AGRO ANIMAL HEALTH SA DE CV

19.1.1 COMPANY SNAPSHOT

19.1.2 PRODUCT PORTFOLIO

19.1.3 RECENT DEVELOPMENT

19.2 ALPHACHEM

19.2.1 COMPANY SNAPSHOT

19.2.2 PRODUCT PORTFOLIO

19.2.3 RECENT DEVELOPMENT

19.3 ANDOCI

19.3.1 COMPANY SNAPSHOT

19.3.2 PRODUCT PORTFOLIO

19.3.3 RECENT DEVELOPMENT/NEWS

19.4 AVIMEX SALUD ANIMAL

19.4.1 COMPANY SNAPSHOT

19.4.2 PRODUCT PORTFOLIO

19.4.3 RECENT DEVELOPMENT

19.5 PECUARIUS MÉXICO

19.5.1 COMPANY SNAPSHOT

19.5.2 PRODUCT PORTFOLIO

19.5.3 RECENT DEVELOPMENT/NEWS

19.6 PET'S PHARMA

19.6.1 COMPANY SNAPSHOT

19.6.2 PRODUCT PORTFOLIO

19.6.3 RECENT DEVELOPMENT/NEWS

19.7 VETS PHARMA

19.7.1 COMPANY SNAPSHOT

19.7.2 PRODUCT PORTFOLIO

19.7.3 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORT